Scribe, a health care company, recently announced the second release of its leading medical transcription (MT) platform. The new elements of Scribe's MT Platform include productivity enhancements that lower cost, decrease keystrokes, and deliver enhanced quality transcription.
"In the past year, numerous transcription companies have purchased Scribe's MT Platform due to its security, Web delivery, and management tools. Now our customers will be able to increase productivity with automatic insertion of patient demographics and address information directly from our unique MT Console,"said Mark Boyce, Scribe's chief executive officer. "Furthermore, transcriptionists have the ability to access historical patient information to cross-check and update newly dictated records."
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs